XML 32 R40.htm IDEA: XBRL DOCUMENT v3.3.0.814
Balance Sheet Components (Details) - USD ($)
$ in Millions
Oct. 25, 2015
Jul. 26, 2015
Jan. 25, 2015
Inventories      
Raw materials $ 117   $ 157
Work in-process 91   92
Finished goods 217   234
Total inventories 425   483
Outstanding Inventory Purchase Obligations 442    
Accrued Liabilities and Other Current Liabilities      
Unearned Revenue [1] 229   296
Customer related liabilities [2] 151   143
Accrued payroll and related expenses 98   112
Professional service fees 24   17
Accrued restructuring and other charges 15 [3] $ 18 0
Warranty accrual [4] 13   8
Taxes payable 7   3
Coupon interest on Notes 6   3
Facilities related liabilities 1   8
Other 16   13
Total accrued and other current liabilities 560   603
Other Long-Term Liabilities      
Deferred income tax liability 325   232
Income taxes payable, long-term 76   121
Asset retirement obligation 7   7
Derivative Liability, Noncurrent 3 [5]   0
Deferred Revenue, long-term 1 [6]   108
Other 25   21
Total other long-term liabilities $ 437   $ 489
[1] Unearned revenue primarily includes deferred revenue.
[2] Customer related liabilities primarily includes accrued customer programs. Please refer to Note 1 of the Notes to the Consolidated Financial Statements in our Annual Report on Form 10-K for the fiscal year ended January 25, 2015, for a discussion regarding the nature of accrued customer programs and their accounting treatment related to our revenue recognition policies and estimates.
[3] Please refer to Note 15 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the accrued restructuring and other charges.
[4] Please refer to Note 10 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding the warranty accrual.
[5] Please refer to Note 9 of these Notes to Condensed Consolidated Financial Statements for a discussion regarding our interest rate swap.
[6] Consists primarily of consideration received in advance of our performance obligations under the patent cross licensing agreement that we entered into with Intel Corporation in January 2011. The decrease in deferred revenue, long-term, is a result of revenue recognized during the nine months ended October 25, 2015.